opinion articles

Send us a link

Subscribe to our newsletter

What if We Have to Wait Years for a Coronavirus Vaccine?

What if We Have to Wait Years for a Coronavirus Vaccine?

A silver-bullet vaccine is far from guaranteed. But it's also not the only way out of the pandemic.

When It Comes to Covid-19, Most of Us Have Risk Exactly Backward

When It Comes to Covid-19, Most of Us Have Risk Exactly Backward

We aren't very good at discussing trade-offs, but we need to make some during this pandemic.

Promoting Diversity and Advancing Racial Equity in the Biomedical Sciences

Promoting Diversity and Advancing Racial Equity in the Biomedical Sciences

"The glacial progress our community has made to remedy our historic and present day exclusion, have been chronicled for longer than I have been alive", says Kenneth Gibbs. 

Swiss € 57million Elsevier Deal

Swiss € 57million Elsevier Deal

The publishing contract reads like a classic big deal for journal subscriptions. But then, only a short addendum of 1.5 pages deals with the new Open Access workflow.

Women Scientists Have the Evidence About Sexism

Women Scientists Have the Evidence About Sexism

Centuries of bias have impeded the advance of human knowledge. As the COVID-19 pandemic makes evident, new threats may emerge suddenly. The world cannot protect itself without the intelligence and skill of half the human race.

Cities: Build Networks and Share Plans to Emerge Stronger from COVID-19

Cities: Build Networks and Share Plans to Emerge Stronger from COVID-19

Responses to the pandemic in India's slums, Brazil's favelas and Africa's marketplaces show that networks play a crucial part in making cities more resilient. Let's enhance and empower them.

A Roadmap to Restore Science in Government Decisions

A Roadmap to Restore Science in Government Decisions

We do not have to live in a constant state of fear that our health is being put at-risk. We can restore and strengthen science-based decision-making processes that are protected from political interference. Today, we are releasing our first set of recommendations providing a roadmap for how the fede

A Conversation with a data integrity specialist who works to keep published images honest

A Conversation with a data integrity specialist who works to keep published images honest

Kaoru Sakabe is academic publishing’s version of an in-house detective. In 2017, she and editors at the Journal of Biological Chemistry (JBC) conducted a pilot study looking for image manipulation in accepted papers. When 10% of papers came back with a possible issue, the team was shocked.

Switzerland is Not an Island

Switzerland is Not an Island

Switzerland will soon vote on whether to cancel the agreement on the free movement of persons, thus terminating the well-established Bilateral Agreements with the EU. Only by networking fully with its European neighbors and the world in general, can the high standards the Swiss hold for themselves be maintained.

How Can Your Research Have More Impact? Five Key Principles and Practical Tips for Effective Knowledge Exchange

How Can Your Research Have More Impact? Five Key Principles and Practical Tips for Effective Knowledge Exchange

Generating new knowledge is a relatively straightforward concept compared with the more unknown territory of getting knowledge to those that might need it.

Young Researcher Groups Reaffirm Support for Plan S

Young Researcher Groups Reaffirm Support for Plan S

Leaked letter to Commission shows major pushback against ERC Scientific Council's doubt over open-access initiative

Will COVID-19 Mark the End of Scientific Publishing As We Know It?

Will COVID-19 Mark the End of Scientific Publishing As We Know It?

Under the pressure of a global health crisis, the argument for open access has sunk in. Is this the catalyst that breaks up the bonds of an old publishing model once and for all?

Two Steps Forward, One Step Back - The Pandemic's Impact on Open Access Progress

Two Steps Forward, One Step Back - The Pandemic's Impact on Open Access Progress

The COVID pandemic may leave us stuck between a growing consensus that open science is the superior way to drive progress and an inability to invest what may be needed to make it happen.